The group’s principal activity is to provide management consulting services. The group offer clinical, regulatory, pharmaceutical development and strategic support. The group's customers include FeRx, Corvascular, Biostar, Situs, David Pharmaceuticals, Accumetrics, MicroHeart, ConjuChem, Biomarin, Onyx, Alza, Matrix, Inhale, Corvas, and Onyx. The group operates from the United States, Canada and Europe.
